Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Rodriguez

Showing results (51-60 of 251) with videos related to

Pageof 26
Sort By:
Biological Chemistry|August 26, 2014
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune responseMichael Panos, George P Christophi, Moses Rodriguez, et al.
Expert Opinion on Investigational Drugs|June 14, 2021
Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trialsRujapope Sutiwisesak, Terry C Burns, Moses Rodriguez, et al.
Journal of Neuroinflammation|July 9, 2008
Acute hemorrhagic demyelination in a murine model of multiple sclerosisIstvan Pirko, Georgette L Suidan, Moses Rodriguez, et al.
International Immunology|April 13, 2005
Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infectionDaren R Ure, Thomas E Lane, Michael T Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Retraction: Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibodyKoji Iijima, Takao Kobayashi, Moses Rodriguez, et al.
Advances in Experimental Medicine and Biology|August 21, 2012
Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG?Arthur E Warrington, Virginia Van Keulen, Larry R Pease, et al.
European Journal of Immunology|February 19, 2004
Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic miceAshutosh K Mangalam, Meenakshi Khare, Christopher Krco, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Disappearing "T1 black holes" in an animal model of multiple sclerosisIstvan Pirko, Aaron Johnson, Jeff Gamez, et al.
Seminars in Pediatric Neurology|November 7, 2017
The Spectrum of Inflammatory Acquired Demyelinating Syndromes in ChildrenRinze Neuteboom, Colin Wilbur, Danielle Van Pelt, et al.
European Journal of Immunology|February 22, 2002
Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficitsPaul D Murray, Dorian B McGavern, Larry R Pease, et al.
Pageof 26

Showing results (51-60 of 251) with videos related to

Sort By:
Pageof 26
Biological Chemistry|August 26, 2014
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune responseMichael Panos, George P Christophi, Moses Rodriguez, et al.
Expert Opinion on Investigational Drugs|June 14, 2021
Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trialsRujapope Sutiwisesak, Terry C Burns, Moses Rodriguez, et al.
Journal of Neuroinflammation|July 9, 2008
Acute hemorrhagic demyelination in a murine model of multiple sclerosisIstvan Pirko, Georgette L Suidan, Moses Rodriguez, et al.
International Immunology|April 13, 2005
Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infectionDaren R Ure, Thomas E Lane, Michael T Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Retraction: Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibodyKoji Iijima, Takao Kobayashi, Moses Rodriguez, et al.
Advances in Experimental Medicine and Biology|August 21, 2012
Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG?Arthur E Warrington, Virginia Van Keulen, Larry R Pease, et al.
European Journal of Immunology|February 19, 2004
Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic miceAshutosh K Mangalam, Meenakshi Khare, Christopher Krco, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Disappearing "T1 black holes" in an animal model of multiple sclerosisIstvan Pirko, Aaron Johnson, Jeff Gamez, et al.
Seminars in Pediatric Neurology|November 7, 2017
The Spectrum of Inflammatory Acquired Demyelinating Syndromes in ChildrenRinze Neuteboom, Colin Wilbur, Danielle Van Pelt, et al.
European Journal of Immunology|February 22, 2002
Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficitsPaul D Murray, Dorian B McGavern, Larry R Pease, et al.
Pageof 26